Synapse Sessions: Targeting Iron in MSA - Dr Daniel Claassen on ATH434
Dr Daniel Claassen, Alterity's Chief Medical Adviser, on the MSA diagnostic journey, the unique iron-targeting mechanism behind ATH434, and why the Phase 2 data - consistent across multiple clinical measures - convinced him to join the team ahead of Phase 3.
Share your feedback
Discover